rolofylline has been researched along with trichlormethiazide in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 8 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Karasawa, A; Kusaka, H; Nagashima, K | 2 |
Karasawa, A; Kobayashi, T; Kusaka, H; Yamagata, T | 1 |
Karasawa, A; Kusaka, H; Sato, K; Yao, K | 1 |
Karasawa, A; Kusaka, H | 1 |
Karasawa, A; Kobayashi, T; Mizumoto, H | 1 |
Karasawa, A; Kusaka, H; Nagashima, K; Sato, K | 1 |
Karasawa, A; Kusaka, H; Nagashima, K; Nomura, H | 1 |
8 other study(ies) available for rolofylline and trichlormethiazide
Article | Year |
---|---|
Effects of KW-3902, an adenosine A1-receptor antagonist, on ascites volume in puromycin aminonucleoside (PAN)-induced nephrotic rats.
Topics: Animals; Ascites; Diuretics; Edema; Furosemide; Male; Nephrosis; Purinergic P1 Receptor Antagonists; Puromycin Aminonucleoside; Rats; Rats, Wistar; Sodium Chloride Symporter Inhibitors; Trichlormethiazide; Xanthines | 1995 |
Protective effects of KW-3902, an adenosine A1-receptor antagonist, against cisplatin-induced acute renal failure in rats.
Topics: Absorption; Acute Kidney Injury; Administration, Oral; Animals; Blood Urea Nitrogen; Cisplatin; Creatinine; Disease Models, Animal; Furosemide; Glomerular Filtration Rate; Injections, Intravenous; Kidney Tubules; Male; Potassium; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Renal Circulation; Sodium; Trichlormethiazide; Water; Xanthines | 1995 |
Diuretic effects of KW-3902, a novel adenosine A1-receptor antagonist, in anesthetized dogs.
Topics: Anesthesia; Animals; Diuretics; Dogs; Electrolytes; Female; Furosemide; Glomerular Filtration Rate; Hemodynamics; Male; Purinergic P1 Receptor Antagonists; Renal Circulation; Trichlormethiazide; Urodynamics; Xanthines | 1994 |
Protective effects of KW-3902, a novel adenosine A1-receptor antagonist, against gentamicin-induced acute renal failure in rats.
Topics: Acute Kidney Injury; Administration, Oral; Animals; Disease Models, Animal; Furosemide; Gentamicins; Injections, Subcutaneous; Kidney; Male; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Trichlormethiazide; Xanthines | 1994 |
Effects of repeated administration of KW-3902, a novel adenosine A1-receptor antagonist, on its pharmacological actions.
Topics: Acute Kidney Injury; Adenosine; Adenosine-5'-(N-ethylcarboxamide); Administration, Oral; Animals; Diuretics; Furosemide; Glycerol; Heart Rate; Male; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Trichlormethiazide; Urination; Xanthines | 1993 |
Diuretic effects of KW-3902 (8-(noradamantan-3-yl)-1,3-dipropylxanthine), a novel adenosine A1 receptor antagonist, in conscious dogs.
Topics: Animals; Diuretics; Dogs; Female; Furosemide; Purinergic P1 Receptor Antagonists; Trichlormethiazide; Xanthines | 1993 |
Effects of KW-3902, a novel adenosine A1-receptor antagonist, on cephaloridine-induced acute renal failure in rats.
Topics: Acute Kidney Injury; Animals; Cephaloridine; Diuretics; Electrolytes; Furosemide; Male; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Trichlormethiazide; Xanthines | 1994 |
Antihypertensive effects of KW-3902, an adenosine A1-receptor antagonist, in Dahl salt-sensitive rats.
Topics: Animals; Diet; Diuretics; Dose-Response Relationship, Drug; Furosemide; Hypertension; Male; Purinergic P1 Receptor Antagonists; Rats; Rats, Inbred Strains; Time Factors; Trichlormethiazide; Xanthines | 1995 |